Latest Trials Latest NewsFAQ

University Of Maryland, Baltimore

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1807-01-01

Employees: 7.3K

Market Cap: -

Website: http://www.umaryland.edu

Clinical Trials

Assessing Online Interventions for Men's' Mental Health and Wellbeing

Not Applicable

Completed

Conditions: Mental Health Wellness 1

Interventions: Behavioral: Screening for Mental Health & Man Therapy
Behavioral: Screening for Mental Health only

First Posted Date: 2016-05-27

Last Posted Date: 2022-02-10

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 554

Registration Number: NCT02785471

Locations: 🇺🇸
University of Maryland Baltimore, Baltimore, Maryland, United States

Pasireotide Treatment for Neuroendocrine Tumor

Phase 4

Withdrawn

Conditions: Gastro-enteropancreatic Neuroendocrine Tumor

Interventions: Drug: Pasireotide
Drug: Diazoxide

First Posted Date: 2016-05-20

Last Posted Date: 2022-03-04

Lead Sponsor: University of Maryland, Baltimore

Registration Number: NCT02779257

A Different Approach to Preventing Thrombosis

Phase 3

Completed

Conditions: Pulmonary Embolism
Venous Thromboembolism

Interventions: Drug: VTE prophylaxis with Enoxaparin 30mg BID
Drug: VTE prophylaxis with Aspirin 81mg BID

First Posted Date: 2016-05-17

Last Posted Date: 2022-01-05

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 329

Registration Number: NCT02774265

Locations: 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States

Prospective, Randomized Controlled Comparison of TERUMO SurFlash Plus Versus BD Insyte Autoguard in an Urban ED

Not Applicable

Completed

Conditions: Catheters
Catheterization, Peripheral

Interventions: Device: Terumo SurFlash Plus catheter
Device: BD Insyte Autoguard catheter

First Posted Date: 2016-05-11

Last Posted Date: 2019-11-04

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 600

Registration Number: NCT02769442

Locations: 🇺🇸
Mercy Medical Center, Baltimore, Maryland, United States

A Safety and Immunogenicity Trial of IHV01

Phase 1

Completed

Conditions: HIV Infection

Interventions: Biological: 300 ug FLSC vaccine
Biological: 75 ug FLSC vaccine
Biological: Placebo
Biological: 150 ug FLSC vaccine

First Posted Date: 2016-04-29

Last Posted Date: 2021-12-16

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 65

Registration Number: NCT02756208

Locations: 🇺🇸
University of Maryland, Institute of Human Virology, Baltimore, Maryland, United States

Bronchial Mapping (GCC 1635)

Recruiting

Conditions: Thoracic Cancer

First Posted Date: 2016-04-20

Last Posted Date: 2024-05-07

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 40

Registration Number: NCT02745548

Locations: 🇺🇸
Ummc Msgcc, Baltimore, Maryland, United States

Safety, Tolerability and Efficacy of Sofosbuvir, Velpatasvir, and Voxilaprevir in Subjects With Previous DAA Experience

Phase 2

Completed

Conditions: Chronic Hepatitis C

Interventions: Drug: Sofosbuvir/Velpatasvir/Voxilaprevir

First Posted Date: 2016-04-20

Last Posted Date: 2022-03-10

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 77

Registration Number: NCT02745535

Locations: 🇺🇸
Institute of Human Virology, Baltimore, Maryland, United States

1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer

Terminated

Conditions: Healthy Volunteers

Interventions: Other: Phlebotomy - Blood sampling for GP88 at MM
Procedure: SOC Tissue biopsy

First Posted Date: 2016-03-07

Last Posted Date: 2019-11-07

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 417

Registration Number: NCT02700776

Locations: 🇺🇸
University of Maryland, Greenebaum Cancer Center, Baltimore, Maryland, United States
🇺🇸
Baltimore Washington Medical Center, Glen Burnie, Maryland, United States

Loop Drainage: Effectiveness in Treating Cutaneous Abscesses

Not Applicable

Terminated

Conditions: Abscess of Skin and/or Subcutaneous Tissue

Interventions: Procedure: Traditional Incision and Drainage.
Procedure: Loop drainage

First Posted Date: 2016-03-03

Last Posted Date: 2022-01-05

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 5

Registration Number: NCT02697279

Locations: 🇺🇸
University of Maryland Medical Systems, Baltimore, Maryland, United States

Lung SBRT Motion Management (GCC 1619)

Terminated

Conditions: Lung Cancer

First Posted Date: 2016-03-01

Last Posted Date: 2024-05-08

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 40

Registration Number: NCT02695680

Locations: 🇺🇸
Ummc Msgcc, Baltimore, Maryland, United States
🇺🇸
Upper Chesapeake Health, Bel Air, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy